CLINICAL_TRIALS
trial_result
· 2017-01-26
Clinical Trial Update: Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial evaluating liraglutide for improving blood glucose control in adults with Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED